Raidium has built what it calls the world’s first radiological AI-native foundation model, designed to address complex radiology needs across clinical practice and research. Its platform is embedded in an interactive viewer — described as the “GPT of radiology” — enabling detailed 3D segmentation, advanced measurements, and automated analysis of complex biomarkers. The model can analyze the entire human body to tackle cases such as metastatic cancer spread and virtual liver biopsies for NASH, producing comprehensive automated reports. Raidium reports its technology operates up to 2,500 times faster than manual methods. In under two years the company has established partnerships with French academic centers including AP-HP and Centre Imagerie du Nord and secured initial contracts with pharmaceutical clients. The company intends to use its recent funding to accelerate technological leadership, expand in Europe and the United States, and advance regulatory milestones including FDA approval and CE marking.

Total raised

$13M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2024